| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3644482
Max Phase: Preclinical
Molecular Formula: C26H36N2O3
Molecular Weight: 424.59
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC(C)(C)c1ccccc1N1CCN(C(=O)C23CC4CC(CC(C(=O)O)(C4)C2)C3)CC1
Standard InChI: InChI=1S/C26H36N2O3/c1-24(2,3)20-6-4-5-7-21(20)27-8-10-28(11-9-27)22(29)25-13-18-12-19(14-25)16-26(15-18,17-25)23(30)31/h4-7,18-19H,8-17H2,1-3H3,(H,30,31)
Standard InChI Key: UFIQNYCAFNWRET-UHFFFAOYSA-N
Associated Targets(Human)
Plasma retinol-binding protein 718 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 424.59 | Molecular Weight (Monoisotopic): 424.2726 | AlogP: 4.30 | #Rotatable Bonds: 3 |
| Polar Surface Area: 60.85 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.46 | CX Basic pKa: 3.33 | CX LogP: 4.51 | CX LogD: 1.88 |
| Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.79 | Np Likeness Score: -0.69 |
References
| 1. (2014) Derivatives of N-acyl-N‚Ä=-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes, |
Source
Source(1):